EP4743125A1 - Method of treating prostate cancer - Google Patents

Method of treating prostate cancer

Info

Publication number
EP4743125A1
EP4743125A1 EP24748133.6A EP24748133A EP4743125A1 EP 4743125 A1 EP4743125 A1 EP 4743125A1 EP 24748133 A EP24748133 A EP 24748133A EP 4743125 A1 EP4743125 A1 EP 4743125A1
Authority
EP
European Patent Office
Prior art keywords
prostate cancer
treating prostate
treating
cancer
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24748133.6A
Other languages
German (de)
French (fr)
Inventor
Mariana Carbini
Palanichamy Ilankumaran
Alton Oliver Sartor
Celine Christiana Anna Wilke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of EP4743125A1 publication Critical patent/EP4743125A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Oncology (AREA)
EP24748133.6A 2023-07-11 2024-07-09 Method of treating prostate cancer Pending EP4743125A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363512925P 2023-07-11 2023-07-11
PCT/IB2024/056674 WO2025012812A1 (en) 2023-07-11 2024-07-09 Method of treating prostate cancer

Publications (1)

Publication Number Publication Date
EP4743125A1 true EP4743125A1 (en) 2026-05-20

Family

ID=92043063

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24748133.6A Pending EP4743125A1 (en) 2023-07-11 2024-07-09 Method of treating prostate cancer

Country Status (8)

Country Link
EP (1) EP4743125A1 (en)
KR (1) KR20260035965A (en)
CN (1) CN121487759A (en)
AU (1) AU2024295743A1 (en)
IL (1) IL325454A (en)
MX (1) MX2026000326A (en)
TW (1) TW202502394A (en)
WO (1) WO2025012812A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023539990A (en) 2020-07-13 2023-09-21 ポイント バイオファーマ インコーポレイテッド Radiopharmaceuticals and methods
US11129912B1 (en) 2020-07-13 2021-09-28 POINT Biopharma Inc. Radiopharmaceutical and methods

Also Published As

Publication number Publication date
TW202502394A (en) 2025-01-16
WO2025012812A1 (en) 2025-01-16
CN121487759A (en) 2026-02-06
KR20260035965A (en) 2026-03-13
AU2024295743A1 (en) 2026-01-08
IL325454A (en) 2026-02-01
MX2026000326A (en) 2026-02-03

Similar Documents

Publication Publication Date Title
IL320743A (en) Method of treating prostate cancer
IL320332A (en) Methods for treating cancer
EP4111202A4 (en) Methods of treating cancer
IL289811A (en) Method of treating cancer
IL325326A (en) Method of treating cancer with indoline inhibitors of kif18a
IL320962A (en) Methods of treating advanced solid tumors
IL325454A (en) Method of treating prostate cancer
IL314798A (en) Methods of treating prostate cancer
IL312155A (en) Method of cancer treatment
IL272390A (en) Methods of treating cancer
CA3274501A1 (en) Method of treating prostate cancer
IL315569A (en) Methods of treating cancer
HK40122526A (en) Methods of treating prostate cancer
IL326327A (en) Treatment of prostate cancer
HK40087831A (en) Methods of treating prostate cancer
IL312332A (en) Methods of treating cancer
IL320448A (en) Methods of treating cancer with sotorasib
CA3297160A1 (en) Method for treating prostate cancer
CA3265149A1 (en) Methods of treating prostate cancer using exicorilant and enzalutamide
GB202412414D0 (en) Methods for treating cancer
GB202013074D0 (en) Method of treatment for cancer
IL326216A (en) Combination therapy for treating prostate cancer
CA3310617A1 (en) Methods of treating cancer
AU2024377510A1 (en) Methods of treating cancer
CA3293232A1 (en) Methods of treating cancer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE